Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
about
Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin conditionMechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitisEpidermal permeability barrier defects and barrier repair therapy in atopic dermatitisCaMKII regulates the strength of the epithelial barrier.Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis.Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.Regulation of the dynamic chromatin architecture of the epidermal differentiation complex is mediated by a c-Jun/AP-1-modulated enhancer.Vitamin d, the cutaneous barrier, antimicrobial peptides and allergies: is there a link?Food allergy enhances allergic asthma in miceDysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.Synergy of understanding dermatologic disease and epidermal biology.IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized MiceEpidermal Langerhans cells tune skin reactivity to contact allergens.Genetics of allergy and allergic sensitization: common variants, rare mutationsHyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.Exploring the origins of asthma: Lessons from twin studiesThe contribution of twin studies to the understanding of the aetiology of asthma and atopic diseasesActivation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.The stratum corneum comprises three layers with distinct metal-ion barrier properties.Overview of atopic dermatitisMechanisms of Disease of Eosinophilic Esophagitis.The Role of Skin Barrier in the Pathogenesis of Food AllergyTuning of protein kinase circuitry by p38α is vital for epithelial tissue homeostasis.Lidocaine inhibits staphylococcal enterotoxin-stimulated activation of peripheral blood mononuclear cells from patients with atopic dermatitis.Novel mechanism of cytokine-induced disruption of epithelial barriers: Janus kinase and protein kinase D-dependent downregulation of junction protein expressionDesmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting.IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunizationWarm, humid, and high sun exposure climates are associated with poorly controlled eczema: PEER (Pediatric Eczema Elective Registry) cohort, 2004-2012.Epidermal cell turnover across tight junctions based on Kelvin's tetrakaidecahedron cell shape.Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasisFilaggrin Mutation in Korean Patients with Atopic Dermatitis.Food allergy: temporal trends and determinants.Tight junction-related human diseases.Epidermal barriersEvolving concepts of neonatal skin.Recent advances in epidemiology and prevention of atopic eczema.Epidermal polarity genes in health and diseaseSpecific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.Dissecting the formation, structure and barrier function of the stratum corneum.Sphingosine-1-phosphate as signaling molecule in the skin: Relevance in atopic dermatitis.
P2860
Q26822766-8448B3F3-7C82-439E-9161-78651AFE74AFQ26827984-D6D7FF1E-14A9-484F-ABA4-CA0A1F84E6ADQ27024192-FE559F40-9121-4E2D-A9EE-03BD1C4E401AQ30661551-5E82576A-320D-47E8-A93B-0500DEE6AE2CQ33554604-2D5874E9-0B13-45BC-B7FC-93B95D960949Q33587005-AD505A16-274E-4094-B90F-D8D67D6852AAQ33955235-BB4F351D-A40B-4F47-9EA5-497D05833C35Q34036550-F4CC4876-DA0C-477F-8D45-3062A0A0E75DQ34631164-61F801CC-1FF1-46C5-BFCA-3407BEB7043BQ35532126-58D8E0BA-7707-4CF3-9233-6F67BDE27086Q35699059-BD92FA86-0C6E-4360-A181-C4EF189304F2Q35729603-92C9A749-2478-457A-AF7C-D24400DE3F6DQ35913763-8B464D8F-9324-408F-8E77-E55BE4E1117FQ36176674-4BC76F7E-02E3-4253-9E42-EA3FEAF341F6Q36192968-BE1FD145-9EC3-40C5-A17C-B68F3B8AD95EQ36239426-88E865C0-5C49-4608-B746-2BF926ABA1B8Q36300616-8C7166C1-C1C5-4F81-95E5-655F453228F2Q36692559-135F747D-BCE0-4260-9553-C92A1BF6912DQ36791961-3DBB4940-0E13-4768-9F14-8B1048D3E609Q36813256-AA159C9B-FE83-4052-A4BA-9B65CD11D4E0Q37031313-BA752F3B-4299-4944-8041-34AF5AF484BAQ37055921-090271F2-4387-4F38-AB93-A855CDB7E779Q37099699-3C0AED8E-469F-4596-9C28-084986C4D1B7Q37115130-87F4FCCD-F60A-4546-949B-834752B083C5Q37197950-3EB255BE-5483-4516-B649-E882629EE6B6Q37218675-2C514742-606D-4A4E-BEBC-884D82B03AC6Q37275024-9A2E23DC-D652-456A-ACD5-ECB170E30C00Q37407574-0CCA6F40-BEDC-4BA7-A569-E90196FA197AQ37452073-C324FD2A-2718-4BB8-AE57-808F449E0F41Q37452229-0927731A-287A-4DAE-A408-5D30F8CDAA98Q37622167-8A0FC2C0-41D4-4687-B480-F1EF17A5F50DQ38020784-857C648B-CC45-4F88-A552-CD6185721A4DQ38077200-6752E184-9EE0-465C-BACF-58A8E1FBBA65Q38201396-86184235-933C-4963-8050-3FB067BE75AFQ38268891-49D11914-FF96-4B6B-B274-A28375478FDEQ38269231-D248CC13-53D5-44A5-A15F-9F18CF4E9552Q38276290-3BDA59E7-7533-41A1-AE46-D5229C3B6B0DQ38299792-49916C26-F91B-4CCB-89C5-53225830438EQ38392463-DC21FD44-451B-4045-B989-95E3F179777CQ38539738-5642526F-A1C6-4C2E-8196-0C2EC412E938
P2860
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@en
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@nl
type
label
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@en
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@nl
prefLabel
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@en
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@nl
P2860
P50
P356
P1476
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
@en
P2860
P304
P356
10.1172/JCI57416
P407
P577
2012-02-01T00:00:00Z